Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/05/2018
Entire Document
 


Case 18-10518-KG    Doc 446    Filed 06/29/18    Page 4 of 11

 

In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: May 1, 2018 - May 31, 2018

 

MOR - 1

Consolidated Schedule of Cash Receipts and Disbursements (1)

For the Period: May 1, 2018 - May 31, 2018

(Unaudited)

 

$ USD ‘000s

   May 1, 2018 - May 31, 2018      Cumulative
Since Filing
 

Beginning Cash Balance (Book)

   $ 4,519      $ 21,372  

Receipts

     

Operating Receipts

     24,980        33,959  

Miscellaneous Receipts

     13        230  
  

 

 

    

 

 

 

Total Receipts

     24,993        34,189  

Operating Disbursements

     

Payroll & Benefits / Contractors

     (3,682      (6,469

Inventory

     (146      (2,266

Manufacturing and Logistics

     (69      (77

Gross to Net Disbursements

     (7,620      (19,941

Marketing / Commercial Operations

     (1,482      (14,370

Ordinary Course Professionals

     (286      (287

Rent / Facilities / Equipment

     (139      (279

Insurance

     (76      (152

IT / Utilities

     (100      (174

Regulatory and Compliance

     (280      (287

Other G&A

     (186      (405
  

 

 

    

 

 

 

Total Operating Disbursements

     (14,066      (44,705

Operating Cash Flow

     10,927        (10,516 ) 

Reorganization Costs

     

DIP Loan Interest and Fees

     (233      (286

US Trustee Fees

     —          (121

Restructuring Professional Fees

     —          (439
  

 

 

    

 

 

 

Total Reorganization Costs

     (233      (846

Total Disbursements

   $ (14,299    $ (45,551
  

 

 

    

 

 

 

Lender Professional Fees

     (103      (501

Net Cash Flow

   $ 10,591      $ (11,863

DIP Draw - Cash

     2,000        7,600  
  

 

 

    

 

 

 

Ending Cash Balance (Book)

   $ 17,109      $ 17,109  

Notes:

 

(1) The Schedule of Cash Receipts and Disbursements is presented on a book basis.